These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3513703)

  • 1. Biochemical classification of Clostridium botulinum type C and D strains and their nontoxigenic derivatives.
    Oguma K; Yamaguchi T; Sudou K; Yokosawa N; Fujikawa Y
    Appl Environ Microbiol; 1986 Feb; 51(2):256-60. PubMed ID: 3513703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transfer of neurotoxigenicity from Clostridium butyricum to a nontoxigenic Clostridium botulinum type E-like strain.
    Zhou Y; Sugiyama H; Johnson EA
    Appl Environ Microbiol; 1993 Nov; 59(11):3825-31. PubMed ID: 8285687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interconversion of type C and D strains of Clostridium botulinum by specific bacteriophages.
    Eklund MW; Poysky FT
    Appl Microbiol; 1974 Jan; 27(1):251-8. PubMed ID: 4589131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interspecies conversion of Clostridium botulinum type C to Clostridium novyi type A by bacteriophage.
    Eklund MW; Poysky FT; Meyers JA; Pelroy GA
    Science; 1974 Nov; 186(4162):456-8. PubMed ID: 4606682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomics of Clostridium botulinum group III strains.
    Sakaguchi Y; Suzuki T; Yamamoto Y; Nishikawa A; Oguma K
    Res Microbiol; 2015 May; 166(4):318-25. PubMed ID: 25111022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Observations on bacteriophages of Clostridium botulinum type C isolates from different sources and the role of certain phages in toxigenicity.
    Hariharan H; Mitchell WR
    Appl Environ Microbiol; 1976 Jul; 32(1):145-58. PubMed ID: 61735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phage conversion to hemagglutinin production in Clostridium botulinum types C and D.
    Oguma K; Iida H; Shiozaki M
    Infect Immun; 1976 Sep; 14(3):597-602. PubMed ID: 786888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serological studies of Clostridium botulinum type E and related organisms. II. Serology of spores.
    Solomon HM; Lynt RK; Kautter DA; Lilly T
    J Bacteriol; 1969 May; 98(2):407-14. PubMed ID: 4891254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigenic relationships among the proteolytic and nonproteolytic strains of Clostridium botulinum.
    Solomon HM; Lynt RK; Kautter DA; Lilly T
    Appl Microbiol; 1971 Feb; 21(2):295-9. PubMed ID: 4927406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multilocus enzyme electrophoresis of Clostridium argentinense (Clostridium botulinum toxin type G) and phenotypically similar asaccharolytic clostridia.
    Altwegg M; Hatheway CL
    J Clin Microbiol; 1988 Nov; 26(11):2447-9. PubMed ID: 3069865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Extrachromosomal genetic elements of Clostridium botulinum. I. Plasmids of toxigenic and atoxigenic strains of Clostridium botulinum type A].
    Evstigneev VI; Smirnov EV; Rudoĭ BA; Surkov SV; Supotnitskiĭ MV; Telitsyn AM
    Mol Gen Mikrobiol Virusol; 1993; (2):16-21. PubMed ID: 8515745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Clostridium botulinum, Clostridium argentinense, and related organisms by cellular fatty acid analysis.
    Ghanem FM; Ridpath AC; Moore WE; Moore LV
    J Clin Microbiol; 1991 Jun; 29(6):1114-24. PubMed ID: 1864927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of type A, B, and E botulism neurotoxin genes in Clostridium botulinum and other Clostridium species by PCR: evidence of unexpressed type B toxin genes in type A toxigenic organisms.
    Franciosa G; Ferreira JL; Hatheway CL
    J Clin Microbiol; 1994 Aug; 32(8):1911-7. PubMed ID: 7989542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cloning of a DNA sequence unique to Clostridium botulinum group I by selective hybridization.
    McKinney MW; Levett PN; Haylock RW
    J Clin Microbiol; 1993 Jul; 31(7):1845-9. PubMed ID: 8349762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigenicity of converting phages obtained from Clostridium botulinum types C and D.
    Oguma K; Iida H; Shiozaki M; Inoue K
    Infect Immun; 1976 Mar; 13(3):855-60. PubMed ID: 773828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasmids in Clostridium botulinum and related Clostridium species.
    Strom MS; Eklund MW; Poysky FT
    Appl Environ Microbiol; 1984 Nov; 48(5):956-63. PubMed ID: 6391384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Boticinogeny and actions of the bacteriocin.
    Anastasio KL; Soucheck JA; Sugiyama H
    J Bacteriol; 1971 Jul; 107(1):143-9. PubMed ID: 4935316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High and low toxin production by a non-toxigenic strain of Clostridium botulinum type C following infection with type C phages of different passage history.
    Oguma K; Iida H
    J Gen Microbiol; 1979 May; 112(1):203-6. PubMed ID: 383896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of Clostridium botulinum by strains of Clostridium perfringens isolated from soil.
    Smith LD
    Appl Microbiol; 1975 Aug; 30(2):319-23. PubMed ID: 169734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxin production by Clostridium botulinum type A under various fermentation conditions.
    Siegel LS; Metzger JF
    Appl Environ Microbiol; 1979 Oct; 38(4):606-11. PubMed ID: 44175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.